Cellyan Biotechnology Stock (NASDAQ:HKPD)


Chart

Previous Close

$0.83

52W Range

$0.68 - $2.76

50D Avg

$0.87

200D Avg

$1.17

Market Cap

$9.12M

Avg Vol (3M)

$117.56K

Beta

3.61

Div Yield

-

HKPD Company Profile


Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.

Show More

Industry

Medical - Pharmaceuticals

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

HK

Employees

27

IPO Date

Jan 15, 2025

Website

HKPD Performance


Peer Comparison


TickerCompany
ATXGAddentax Group Corp.
TLIHTen-League International Holdings Limited Ordinary Shares
LSHLakeside Holding Limited
JYDJayud Global Logistics Limited
PSIGPS International Group Ltd.
NCEWNew Century Logistics (BVI) Limited
ARTWArt's-Way Manufacturing Co., Inc.
CRGOFreightos Limited Ordinary shares
VRMEVerifyMe, Inc.